Logo

Amersham and GeneBio Collaborate on Proteomics Imaging Software

Jul 16, 2003

NEW YORK, July 16 -- Amersham Biosciences and GeneBio today announced a collaboration in proteomics research.

 

In a joint statement, the companies said that Switzerland-based GeneBio's Melanie 2-D gel analysis software, developed by the Swiss Institute of Bioinformatics, will be integrated into the ImageMaster image analysis application and will be available upon the next release of the software. The companies will continue to collaborate on future software under an agreement expanded from the original collaboration the companies announced in January.

 

Financial details of the agreement were not disclosed.

 

Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.